A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination - Andrews, Sarah F.; Raab, Julie E.; Gorman, Jason; Gillespie, Rebecca A.; Cheung, Crystal S. F.; Rawi, Reda; Cominsky, Lauren Y.; Boyington, Jeffrey C.; Creanga, Adrian; Shen, Chen-Hsiang; Harris, Darcy R.; Olia, Adam S.; et al. (Nature medicine, 2022)
Keywords: 631/250/2152/2153/1571; 631/250/255/1578; Antibodies; Antibodies, Neutralizing; Antibodies, Viral; Binding; Biomedical and Life Sciences; Biomedicine; Cancer Research; Child; Children; Clinical trials; Clinical Trials, Phase I as Topic; Cross-reactivity; Epitopes; Ferritin; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins; Humans; Immunological memory; Infectious Diseases; Influenza; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Lymphocytes B; Memory cells; Metabolic Diseases; Molecular Medicine; Nanoparticles; Neurosciences; Neutralizing; Pandemics; Residues; Stems; Vaccination; Vaccine development; Vaccines; Viruses